Finance

Lists
Why is LZAGF up 7,84%?
Dive Deeper
LZAGF:OTCMKTS
Lonza Group AG
715,55 US$
+7,84%
(+52,00) 1D
14 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LZAGF...
Open
700,00 US$
High
715,55 US$
Low
679,95 US$
Mkt. cap
41,11 მლრდ.
Avg. vol.
235,00
Volume
123,00
52-wk high
755,96 US$
52-wk low
565,14 US$
Beta
1,00
Shares outstanding
70,23 მლნ.
No. of employees
20 ათ.
Open
700,00 US$
High
715,55 US$
Low
679,95 US$
Mkt. cap
41,11 მლრდ.
Avg. vol.
235,00
Volume
123,00
52-wk high
755,96 US$
52-wk low
565,14 US$
Beta
1,00
Shares outstanding
70,23 მლნ.
No. of employees
20 ათ.
News stories
From web sources and news partners
Investing.com
Investing.com
·
19 საათის წინ
Why is Lonza stock rallying today?
Investing.com Australia
Investing.com Australia
·
20 საათის წინ
Lonza shares rise on upgraded mid-term financial targets By Investing.com
Euronext Markets: Real-time Stock Market Data | live
Euronext Markets: Real-time Stock Market Data | live
·
1 დღის წინ
Lonza sets new mid-term targets, confirms 2026 outlook
Profile
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. Wikipedia
About Lonza Group AG
CEOვოლფგანგ ვინანდ
Employees20,1 ათ.
Founded1897
Headquartersბაზელი, ბაზელ-შტადტის კანტონი, შვეიცარია
SectorHealth care
Websitelonza.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
1,69 მლრდ.
1,69 მლრდ.
Cost of goods sold
-
-
1,04 მლრდ.
1,04 მლრდ.
Cost of revenue
-
-
1,04 მლრდ.
1,04 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
253,50 მლნ.
253,50 მლნ.
Operating expense
-
-
252,50 მლნ.
252,50 მლნ.
Total operating expenses
-
-
1,29 მლრდ.
1,29 მლრდ.
Operating income
-
-
395,00 მლნ.
395,00 მლნ.
Other non operating income
-
-
500,00 ათ.
500,00 ათ.
EBT including unusual items
-
-
354,00 მლნ.
354,00 მლნ.
EBT excluding unusual items
-
-
354,00 მლნ.
354,00 მლნ.
Income tax expense
-
-
68,00 მლნ.
68,00 მლნ.
Effective tax rate
-
-
19,21%
19,21%
Other operating expenses
-
-
-1,00 მლნ.
-1,00 მლნ.
Net income
-
-
295,50 მლნ.
295,50 მლნ.
Net profit margin
-
-
17,52%
17,52%
Earnings per share
-
-
-
-
Interest and investment income
-
-
10,00 მლნ.
10,00 მლნ.
Interest expense
-
-
-37,00 მლნ.
-37,00 მლნ.
Net interest expenses
-
-
-27,00 მლნ.
-27,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
564,00 მლნ.
564,00 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები